
A single 3 zzso or 40 zzso intravenous dose of zzso combined with zzso is routinely used in several countries, although the zzso guidelines have recommended zzso at the dose of 1 zzso or 10 zzso A randomized, zzso trial was conducted to determine the optimal intravenous zzso dose, 1 or 3 zzso in cancer patients receiving zzso zzso 

We enrolled 365 patients and randomly assigned them to receive intravenous zzso 3 zzso zzso zzso or 1 zzso zzso group), combined with zzso at an adequate dose fixed as per the zzso risk zzso The primary end point was the proportion of patients with a complete response during the first 24 h after zzso 

The study demonstrated that 1 zzso of zzso was not inferior in effect to 3 zzso For the primary end point, zzso patients were zzso according to the modified zzso zzso zzso Complete protection was achieved in the modified zzso population, zzso and zzso for the 3- and zzso groups, respectively zzso zzso zzso for zzso 

This study showed that 1 zzso zzso is not inferior to 3 zzso when both doses are combined with zzso zzso zzso dose of intravenous zzso should be the recommended zzso regimen for the prevention of acute zzso 

